Serum adiponectin concentrations are decreased in women with endometriosis | Zendy

Yuri Takemura | Zendy; Yutaka Osuga | Zendy; Miyuki Harada | Zendy; Tetsuya Hirata | Zendy; Kaori Koga | Zendy; Chieko Morimoto | Zendy; Yasushi Hirota | Zendy; Osamu Yoshino | Zendy; Tetsu Yano | Zendy; Yuji Taketani | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Serum adiponectin concentrations are decreased in women with endometriosis

Author(s) -

Yuri Takemura,

Yutaka Osuga,

Miyuki Harada,

Tetsuya Hirata,

Kaori Koga,

Chieko Morimoto,

Yasushi Hirota,

Osamu Yoshino,

Tetsu Yano,

Yuji Taketani

Publication year - 2005

Publication title -

human reproduction

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.446

H-Index - 226

eISSN - 1460-2350

pISSN - 0268-1161

DOI - 10.1093/humrep/dei233

Subject(s) - adiponectin , endometriosis , medicine , interquartile range , endocrinology , estrogen , endometrial cancer , gynecology , cancer , obesity , insulin resistance

Adiponectin is a pleiotropic cytokine originally discovered as an adipocyte-specific gene product. Serum adiponectin concentrations have been reported to be low in women with endometrial cancer, breast cancer and uterine leiomyoma, suggesting possible involvement of adiponectin in these estrogen-related diseases. We thus addressed the relevance of adiponectin to endometriosis, an estrogen-dependent disease, in the present study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research